transdermal glp-1 receptor agonist patch clinical trial Stimuli-responsive microneedle patches GLP-1 Receptor Agonist Market Size

These drugs modulate dopaminergic signaling in the mesolimbic system, the brains reward circuit, which is also implicated in addiction

However, by evaluating selective expansion opportunities alongside its primary GLP-1 development efforts, SureNano Science is positioning itself within a broader trend toward diversified therapeutic platforms capable of addressing multiple large and evolving healthcare markets

Now research suggests these meds part of a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may one day be a promising treatment for alcohol use disorder (AUD)

Gastro-intestinal Tract (GIT)

L.BremserS.AlberJ.GiavaliscoP.et al (2020)